荃信生物-B(02509)11月20日斥资99.78万港元回购4.68万股

Core Viewpoint - The company, Zhenxin Biotechnology-B (02509), announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 46,800 shares at a total cost of HKD 997,800 [1] - The buyback price per share ranges from HKD 21 to HKD 21.5 [1] - The buyback is scheduled for November 20, 2025 [1]